Skip to main content

Month: January 2026

VALLOUREC : DISCLOSURE OF TRADING IN OWN SHARES FROM 01/08/2026 TO 01/09/2026

DISCLOSURE OF TRADING IN OWN SHARES FROM 01/08/2026 TO 01/09/2026 Meudon (France), on January 12, 2026 Share buyback program (ISIN Code: FR0013506730) implemented in accordance with the authorization given by the Shareholders’ General Meeting of Vallourec SA (LEI: 969500P2Q1B47H4MCJ34) on May 22, 2025 (ninth resolution).  Day of the transaction   Total daily volume (number of shares) Daily weighted average purchase price of the shares (€) Market Code01/08/2026 77 000 16,3881 XPAR01/08/2026 38 000 16,4233 CEUX01/08/2026 5 000 16,4204 TQEX01/08/2026 5 000 16,4271 AQEU01/09/2026 38 994 16,8053 CEUX01/09/2026 5 000 16,8164 AQEU01/09/2026 5 000 16,8100 TQEX01/09/2026 71 006 16,7784 XPAR  245 000 16,5919  About Vallourec Vallourec is a world leader in premium tubular solutions for the energy markets and...

Continue reading

INTEGRATED MULTI-THREAT HEADBORNE SYSTEM PROTOTYPE TO BE FUNDED AND DEVELOPED FOR U.S. ARMY BY TEAM WENDY CERADYNE AND THEON INTERNATIONAL

Press Release Under a U.S. Army-funded initiative, Team Wendy Ceradyne and Theon International partner to develop an Integrated Multi-Threat Headborne System (IMHS) prototype set to enhance soldier protection and situational awareness.  Bloomberg (THEON:NA) / Reuters (THEON.AS) Salem, New Hampshire – January 12th, 2026. Team Wendy Ceradyne, a leading US-based developer and manufacturer of advanced combat helmets for the Department of Defense, and Theon International Plc (THEON), a global company specializing in electro-optical systems including night vision, thermal imaging, and augmented reality (AR) technologies, have announced a strategic partnership under a US Army Combat Capabilities Development Command (DEVCOM) Soldier Center (SC)-funded initiative. Together, the companies are developing a next generation Integrated Multi-Threat...

Continue reading

Aramis Group – Declaration of transactions on own shares conducted from January 05 to January 09, 2026

PRESS RELEASE Arcueil, January 12, 2026 Declaration of transactions on own shares conducted from January 05 to January 09, 2026 Within the framework of the authorizations granted by the General Assembly on February 4, 2025, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from January 05 to January 09, 2026 (excluding the liquidity contract):Name of the issuer Issuer identifier code Transaction date Financial instrument identifier code Total daily volume (in number of shares) Daily weighted average purchase price of shares MarketAramis Group 9695002Q984W0T41WB42 2026-01-05 FR0014003U94 1,047 4.7738 XPARAramis Group 9695002Q984W0T41WB42 2026-01-06 FR0014003U94 2,109 4.7412 XPARAramis Group 9695002Q984W0T41WB42 2026-01-07 FR0014003U94 2,123 4.7088 XPARAramis...

Continue reading

Michelin: Mr. Florent Menegaux’ term as Managing General Partner is renewed for four years and the nomination of Mr. Philippe Jacquin as General Manager will be proposed at the company’s Shareholders Meeting

                                                                             Clermont-Ferrand, January 12, 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Mr. Florent Menegaux’ term as Managing General Partner is renewed for four years and the nomination of Mr. Philippe Jacquin as General Manager will be proposed at the company’s Shareholders Meeting. SAGES (Société Auxiliaire de Gestion), as Non-Managing General Partner of the Compagnie Générale des Établissements Michelin (CGEM), headed by Mr. Vincent Montagne, has decided to renew Mr. Florent Menegaux’ term as Managing General Partner. Michelin’s Supervisory Board, chaired by Mrs. Barbara Dalibard, has unanimously agreed to this decision on January 12, 2026. Mr. Florent Menegaux’ term will therefore be renewed in accordance with the company’s bylaws for a maximum period of four...

Continue reading

BUREAU VERITAS: Number of shares and voting rights as of December 31, 2025

REGULATED INFORMATION Courbevoie, France – January 12, 2026 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau VeritasDate Number of shares (1) Number of voting rights31/12/2025 453,871,520Theoretical number of voting rights: 560,821,818 Number of exercisable voting rights: 550,602,988  (1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2025, if any.                Bureau Veritas Head Office Tel: + 33 (0)1 55 24 70 00Société Anonyme Tour Alto Fax: + 33 (0)1 55 24 70 01(Limited liability corporation) 4, Place des Saisons www.bureauveritas.comShare capital of EUR 54,464,582.40 92400 Courbevoie  RCS Nanterre 775 690 621 France  Attachment...

Continue reading

Johns Hopkins University Study Gives ESSA Certification for MindPrint Learning’s Universal SpED and Gifted Screener

Independent Research Confirms MindPrint Assessment Reliably Identifies Students Who Need Academic Support and Predicts Achievement OutcomesJohns Hopkins University Study Gives ESSA Certification for MindPrint Learning’s Universal SpED and Gifted ScreenerThe research confirms the reliability and predictive validity of the MindPrint assessment for identifying students’ cognitive strengths and needs.CHICAGO, IL, Jan. 12, 2026 (GLOBE NEWSWIRE) — CHICAGO, IL – January 12, 2026 – MindPrint Learning, a K-12 intervention and acceleration solution now part of Otus, has announced the publication of a comprehensive validation study conducted by Johns Hopkins University’s Center for Research and Reform in Education. The research confirms the reliability and predictive validity of the MindPrint assessment for identifying students’...

Continue reading

Innospec Schedules Fourth Quarter 2025 Earnings Release and Conference Call

ENGLEWOOD, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) — Innospec Inc. (NASDAQ: IOSP) today announced that it will release fourth quarter 2025 earnings results on Tuesday, February 17, 2026, after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, February 18, 2026, at 9:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which can be used to join the conference 5-10 minutes prior to the start time. Online Registration Link: https://register-conf.media-server.com/register/BI401135aee828455e84215dd46099404b An...

Continue reading

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

– Preliminary unaudited Q4 and Full Year 2025 net Attruby® product revenue of $146.0 million and $362.4 million, respectively – Attruby (acoramidis) is rapidly becoming the first-choice therapy for newly diagnosed ATTR-CM patients with 6,629 unique patient prescriptions written by 1,632 prescribers as of December 31, 2025, driven by differentiated clinical data and growing real-world confidence – New TTR amyloid depleter antibody program announced to explore the potential of ATTR-CM disease reversal; program expected to advance into the clinic between 2027 – 2028 – The interim analysis from FORTIFY, BridgeBio’s Phase 3 study of BBP-418 in LGMD2I/R9, demonstrated broad benefit in all subgroups across α-controlled endpoints and a highly clinically meaningful and statistically significant 2.6 point benefit on NSAD...

Continue reading

KOIL Energy Secures Significant Contract with U.S. Oil Company to Deliver an Integrated Subsea Distribution System

HOUSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) — KOIL Energy Solutions, Inc. (OTCQB: KLNG), an international specialist in subsea equipment and services, today announces the award of a significant contract to supply a subsea distribution system for a deepwater project in the Gulf of America.KOIL Energy Subsea Distribution System KOIL Energy will manufacture the subsea umbilical termination assemblies (SUTAs), hydraulic distribution manifolds (HDMs), steel tube flying leads (STFLs), mudmat structures, and ancillary hardware for a subsea tieback project. KOIL’s service team will integrate and test the system, incorporating KOIL’s manufactured equipment alongside equipment from other leading subsea suppliers. This system will tie back to an existing subsea field and control additional subsea assets such as pipeline end manifold (PLEMs)...

Continue reading

HyOrc Advances Green Methanol Commercialization and Completes OTCQB Uplist Application

HOUSTON , Jan. 12, 2026 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCID: HYOR), a clean-energy infrastructure company focused on green methanol and rail decarbonisation, today announced that it has completed and submitted all required documentation for its uplisting to the OTCQB market. The Company also confirmed continued progress on its first industrial green methanol project in Portugal, as demand for compliant marine fuels accelerates under European maritime regulations. HyOrc is in advanced discussions on a long-term (10-year) offtake structure with a European renewable fuels counterparty, designed to cover initial production from its Porto-area facility. The project is expected to begin with a modular unit producing approximately 8 tonnes of green methanol per day, with expansion capacity embedded from the outset. In parallel,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.